The data in the study reinforces the significant costs associated with weight loss products
Side Effects and Risks of GLP-1-Based Medications GLP-1-based treatments are generally well-tolerated and offer multiple health benefits, but like all medications, they can cause side effects
2004 Apr;63(4):641-6.
Common safety concerns circulating online cancer, weight gain, and vitiligo are not supported by credible scientific evidence for standard oral supplementation
En un ensayo clnico de fase 2, la semaglutida a dosis de 0,4mg diarios mostr una resolucin de NASH (sin empeoramiento de fibrosis) en un 59% de los pacientes, comparado con un 14% en el grupo placebo, en 320 pacientes con obesidad, NASH y fibrosis F2-F3 tras 72 semanas de tratamiento
Nat Rev Genet 10 , 540550, (2009)